Dr. Tracy Shibla, APRN
What this data tells you about Dr. Shibla
Dr. Tracy Shibla is a nurse practitioner - family in Orlando, FL, with 9 years in practice. Based on federal Medicare data, Dr. Shibla performed 2,195 Medicare services across 1,798 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shibla received a total of $1,003 from 12 pharmaceutical and/or device companies across 37 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shibla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 | 397 | $3 | $9 |
| Office visit, established patient (30-39 min) | 390 | $65 | $251 |
| Office visit, established patient (20-29 min) | 193 | $43 | $177 |
| New patient office visit (45-59 min) | 167 | $86 | $436 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 127 | $35 | $65 |
| Destruction of precancerous skin growth, 1 | 124 | $21 | $92 |
| Skin biopsy, tangential | 118 | $41 | $139 |
| New patient office visit (30-44 min) | 115 | $59 | $305 |
| Detection test by immunoassay with direct visual observation for influenza virus | 114 | $16 | $49 |
| Destruction of skin growths (warts/lesions), 1-14 | 101 | $50 | $154 |
| Urinalysis, manual | 74 | $3 | $11 |
| Biopsy of related skin growth, each additional growth | 43 | $30 | $69 |
| Chest X-ray, 2 views | 30 | $19 | $90 |
| Drug injection, under skin or into muscle | 29 | $8 | $73 |
| Injection, ketorolac tromethamine, per 15 mg | 28 | $0 | $11 |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 28 | $0 | $0 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 25 | $16 | $49 |
| Detection test by immunoassay with direct visual observation for respiratory syncytial virus | 23 | $13 | $49 |
| Destruction of precancer skin growth, 15 or more growths | 17 | $95 | $233 |
| Inhalation treatment for airway obstruction or sputum production | 14 | $5 | $54 |
| Administration of vaccine | 13 | $11 | $75 |
| Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older) | 13 | $28 | $88 |
| Removal of impacted ear wax by washing | 12 | $10 | $49 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shibla is a clinical cardiology specialist, with above-average Medicare volume (top 7% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shibla experienced with destruction of precancerous skin growths, 2-14?
Does Dr. Shibla receive payments from pharmaceutical companies?
How do Dr. Shibla's costs compare to other nurse practitioner - familys in Orlando?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology